Politico November 25, 2024
By Chelsea Cirruzzo and Ben Leonard

Driving The Day

THE MAHA DEPARTMENT TAKES SHAPE — The potential nominees to run federal agencies during the second Trump administration are aligned on their mission to overhaul some health regulatory agencies, reshape how doctors are paid and shift focus from infectious diseases to chronic diseases.

President-elect Donald Trump on Friday night announced three additional key health nominations: former Florida Rep. Dave Weldon to lead the CDC, Fox News contributor Dr. Janette Nesheiwat to be surgeon general and surgeon Marty Makary to lead the FDA. They join the nominees for HHS secretary, Robert F. Kennedy Jr., and CMS administrator, Dr. Mehmet Oz.

While all those the nominees except Kennedy have medical backgrounds, none have led federal agencies and all share...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: CMS, Congress / White House, FDA, Govt Agencies, HHS
Related Articles:
How should primary care physicians navigate potential health care shifts under the Trump administration?
Musk, DOGE Threaten The Health Of Millions Of Americans
Hospitals and private equity: Scathing Senate report shows concerns cross party lines
Patient Care Experiences Worsens After Private Equity Acquisition of Hospitals
Possible long-term health care implications of a second Trump presidency

Share This Article